UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Reference interval establishment and correlation research of urine thromboxane metabolites: Unveiling new possibilities in platelet activation

Clinica chimica acta, 2024-05, Vol.558, p.119672-119672, Article 119672

2024

Volltextzugriff (PDF)

Development of an immunochromatographic strip for the rapid detection of 11-dehydro-thromboxane B2 in human urine

Chinese Journal of Analytical Chemistry, 2024-09, Vol.52 (9), p.100436, Article 100436

2024

Volltextzugriff (PDF)

Establishment of 11-dehydro-thromboxane B2 time-resolved immunoassay and application in membranous nephropathy

Analytical biochemistry, 2023-09, Vol.677, p.115252-115252, Article 115252

2023

Volltextzugriff (PDF)

Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial

Trials, 2023-03, Vol.24 (1), p.166-166, Article 166

2023

Volltextzugriff (PDF)

First Experience Addressing the Prognostic Utility of Novel Urinary Biomarkers in Patients With COVID-19

Open forum infectious diseases, 2021-07, Vol.8 (7), p.ofab274-ofab274

2021

Volltextzugriff (PDF)

Pentraxin 3 and Platelet Activation in Obese Patients After Gastric Banding

Circulation Journal, 2016/01/25, Vol.80(2), pp.502-511

2016

Volltextzugriff (PDF)

Metamizole and Platelet Inhibition by Aspirin Following on-Pump Coronary Artery Bypass Grafting

Journal of cardiothoracic and vascular anesthesia, 2018-02, Vol.32 (1), p.178-186

2018

Volltextzugriff (PDF)

Urine 11-Dehydro-Thromboxane B2 in Aspirin-Naive Males with Metabolic Syndrome

Journal of clinical medicine, 2022-06, Vol.11 (12), p.3471

2022

Volltextzugriff (PDF)

Prevalence of aspirin resistance in patients with type II diabetes: a descriptive-analytical study

International journal of clinical pharmacology and therapeutics, 2017-06, Vol.55 (6), p.493-497

2017

Volltextzugriff (PDF)

Urinary 11-dehydro thromboxane B2 levels in type 2 diabetic patients before and during aspirin intake

Clinica chimica acta, 2011-07, Vol.412 (15-16), p.1366-1370

2011

Volltextzugriff (PDF)

Impact of flexible insulin therapy on blood glucose variability, oxidative stress and inflammation in type 1 diabetic patients: The VARIAFIT study

Diabetes & metabolism, 2014-09, Vol.40 (4), p.278-283

2014

Volltextzugriff (PDF)

Measurement of urinary 11-dehydro-thromboxane B2 excretion in dogs with gastric dilatation-volvulus

American journal of veterinary research, 2006, Vol.67 (1), p.78-83

2006

Volltextzugriff (PDF)

Supplementation with mixed tocopherols increases serum and blood cell [gamma]-tocopherol but does not alter biomarkers of platelet activation in subjects with type 2 diabetes

The American journal of clinical nutrition, 2006, Vol.83 (1), p.95-102

2006

Volltextzugriff (PDF)

Urinary leukotriene E4 and 11-dehydro-thromboxane B2 excretion in children with bronchial asthma

Allergology international, 2004, Vol.53 (2), p.127-134

2004

Volltextzugriff (PDF)

Study on the Relationship of Metastasis of Colorectal Cancers with Adhesion Molecules (Laminin, Sialyl Lea, and ICAM-1) and Platelet Aggregation (11-dehydro-Thromboxane B2)

Nippon Daicho Komonbyo Gakkai Zasshi, 1999, Vol.52(3), pp.200-207

1999

Volltextzugriff (PDF)

Platelet Volume and Urinary Prostanoid Metabolites in Non-Insulin-Dependent Diabetes Mellitus

Journal of Atherosclerosis and Thrombosis, 1994, Vol.1(2), pp.108-112

1994

Volltextzugriff (PDF)

Purification and characterization of an NAD super(+)-dependent dehydrogenase that catalyzes the oxidation of thromboxane B sub(2) at C-11 from porcine liver. Development and application of 11-dehydro-thromboxane B sub(2) radioimmunoassay to enzyme assay

Biochimica et biophysica acta, Protein structure and molecular enzymology, 1990-01, Vol.1036 (1), p.55-63

1990

Volltextzugriff (PDF)

Fractional conversion of thromboxane B2 to urinary 11-dehydro-thromboxane B2 in man

Pharmacological research communications, 1988-09, Vol.20, p.95-95

1988

Volltextzugriff (PDF)

糖尿病患者における11-Dehydro Thromboxane B2について

糖尿病, 1989/02/28, Vol.32(2), pp.127-130

1989

Volltextzugriff (PDF)

11-Dehydro Thromboxane B2 in Diabetics

Journal of the Japan Diabetes Society, 1989/02/28, Vol.32(2), pp.127-130

1989

Volltextzugriff (PDF)

Measurement of urinary 11-dehydro-thromboxane B2 and 2,3 dinor-6-keto-prostaglandin F1.ALPHA. levels in normal Japanese children

Enshō, 1996, Vol.16 (1), p.43-45

1996

Volltextzugriff (PDF)

Thromboxane biosynthesis and future events in diabetes: the ASCEND trial

European heart journal, 2024-04, Vol.45 (15), p.1355-1367

2024

Volltextzugriff (PDF)

Reappraisal of the clinical pharmacology of low‐dose aspirin by comparing novel direct and traditional indirect biomarkers of drug action

Journal of thrombosis and haemostasis, 2014-08, Vol.12 (8), p.1320-1330

2014

Volltextzugriff (PDF)

Effect of assay specificity on the association of urine 11‐dehydro thromboxane B2 determination with cardiovascular risk

Journal of thrombosis and haemostasis, 2012-12, Vol.10 (12), p.2462-2469

2012

Volltextzugriff (PDF)

Regulation of oxidative stress and inflammation by glycaemic control: evidence for reversible activation of the 5-lipoxygenase pathway in type 1, but not in type 2 diabetes

Diabetologia, 2010-09, Vol.53 (9), p.2068-2070

2010

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(28)

Sprache

Englisch
(25)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

11-Dehydro-Thromboxane B2
(15)
Science & Technology
(15)
Life Sciences & Biomedicine
(14)
Humans
(13)
Male
(10)
Thromboxane B2 - Urine
(10)
Female
(9)
Thromboxane B2 - Analogs & Derivatives
(9)
11-Dehydro-Thromboxane B
(7)
Middle Aged
(7)
Urine
(7)
Adult
(6)
Cardiovascular System & Cardiology
(6)
Aspirin
(5)
Diabetes
(5)
Thromboxane B2
(5)
Aged
(4)
Creatinine
(4)
Peripheral Vascular Disease
(4)
Platelet Aggregation
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Reference interval establishment and correlation research of urine thromboxane metabolites: Unveiling new possibilities in platelet activation

Development of an immunochromatographic strip for the rapid detection of 11-dehydro-thromboxane B2 in human urine

Establishment of 11-dehydro-thromboxane B2 time-resolved immunoassay and application in membranous nephropathy

Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial

First Experience Addressing the Prognostic Utility of Novel Urinary Biomarkers in Patients With COVID-19

Pentraxin 3 and Platelet Activation in Obese Patients After Gastric Banding

Metamizole and Platelet Inhibition by Aspirin Following on-Pump Coronary Artery Bypass Grafting

Urine 11-Dehydro-Thromboxane B2 in Aspirin-Naive Males with Metabolic Syndrome

Prevalence of aspirin resistance in patients with type II diabetes: a descriptive-analytical study

Urinary 11-dehydro thromboxane B2 levels in type 2 diabetic patients before and during aspirin intake

Impact of flexible insulin therapy on blood glucose variability, oxidative stress and inflammation in type 1 diabetic patients: The VARIAFIT study

Measurement of urinary 11-dehydro-thromboxane B2 excretion in dogs with gastric dilatation-volvulus

Supplementation with mixed tocopherols increases serum and blood cell [gamma]-tocopherol but does not alter biomarkers of platelet activation in subjects with type 2 diabetes

Urinary leukotriene E4 and 11-dehydro-thromboxane B2 excretion in children with bronchial asthma

Study on the Relationship of Metastasis of Colorectal Cancers with Adhesion Molecules (Laminin, Sialyl Lea, and ICAM-1) and Platelet Aggregation (11-dehydro-Thromboxane B2)

Platelet Volume and Urinary Prostanoid Metabolites in Non-Insulin-Dependent Diabetes Mellitus

Purification and characterization of an NAD super(+)-dependent dehydrogenase that catalyzes the oxidation of thromboxane B sub(2) at C-11 from porcine liver. Development and application of 11-dehydro-thromboxane B sub(2) radioimmunoassay to enzyme assay

Fractional conversion of thromboxane B2 to urinary 11-dehydro-thromboxane B2 in man

糖尿病患者における11-Dehydro Thromboxane B2について

11-Dehydro Thromboxane B2 in Diabetics

Measurement of urinary 11-dehydro-thromboxane B2 and 2,3 dinor-6-keto-prostaglandin F1.ALPHA. levels in normal Japanese children

Thromboxane biosynthesis and future events in diabetes: the ASCEND trial

Reappraisal of the clinical pharmacology of low‐dose aspirin by comparing novel direct and traditional indirect biomarkers of drug action

Effect of assay specificity on the association of urine 11‐dehydro thromboxane B2 determination with cardiovascular risk

Regulation of oxidative stress and inflammation by glycaemic control: evidence for reversible activation of the 5-lipoxygenase pathway in type 1, but not in type 2 diabetes

Suchergebnisse filtern